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cense.Abstract Purpose: To evaluate the role of the combined techniques of apparent diffusion coefﬁ-
cient (ADC) generated from diffusion-weighted magnetic resonance (MR) imaging (DWI) and
metabolite spectrum acquired by magnetic resonance spectroscopy (MRS) in differentiating benign
from malignant thyroid nodules.
Materials and methods: Thirty-seven patients with 56 thyroid nodules were evaluated with conven-
tional MRI (T1- & T2-WI), DWI (b value 0.500 s/mm2; ADC values were calculated for the thyroid
nodules), andMRS (for the presence or absence of choline peak). The ADC values andMRS ﬁndings
were correlated with the histopathological results.
Results: The mean ADC of the malignant thyroid nodules (0.89 ± 0.27 · 103 mm2/s) was signiﬁ-
cantly lower than that of the mean ADC of the benign thyroid nodules (1.85 ± 0.24 · 103 mm2/
s) (p value <0.0001). ADC value of 1.5 · 103 mm2/s was used as a cut-off value for differentiation
benign from malignant thyroid nodules. The sensitivity, speciﬁcity, PPV&NPV of DWI in differen-
tiating benign frommalignant thyroid nodules were 94%, 95%, 94%&95%, respectively (Kappa test4038955.
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184 M.A. El-Hariri et al.0.84, p value <0.0001), whereas they were 94.7%, 89.2%, 81.8% & 97.1% (Kappa test 0.8, p value
<0.0001) with MRS, and 96%, 100%, 100% & 97% (Kappa test 0.96, p value <0.0001) with both
DWI and MRS.
Conclusion: Both DWI andMRS are useful diagnostic modalities for characterization and differen-
tiation between benign and malignant thyroid nodules. Our preliminary results showed that combi-
nation of DWI with calculated ADC values and metabolite spectrum acquired by MRS add more
information to MRI and should be considered as an additional and complementary tool to conven-
tional MRI for differentiating benign from malignant thyroid nodules.
 2012 Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by Elsevier B.V.
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Thyroid nodules is the most common disorder presenting to
the endocrine surgeon. Most of the lesions are benign with
the incidence of malignancy being only 5%, but the principal
problem facing the clinician is that of identifying the malignant
nodule requiring surgery, which is not always possible with the
available diagnostic modalities (1).
Many studies have been published to predict whether a thy-
roid nodule is benign or malignant on the basis of US ﬁndings.
Several US features have been found to be associated with an
increased risk of thyroid cancer including the presence of cal-
ciﬁcations, hypoechogenicity, irregular margins, absence of a
halo, predominantly solid composition, and intranodule vas-
cularity. However, the sensitivities, speciﬁcities, and negative
and positive predictive values for these criteria are extremely
variable from study to study, and no US feature has both high
sensitivity and high positive predictive values for thyroid can-
cer (2). US with ﬁne-needle aspiration biopsy (FNAB, cytol-
ogy) is considered an effective method for differentiating
between benign and malignant thyroid nodules and almost
exclusively used for de novo diagnosis (3).
Conventional MR imaging cannot differentiate benign from
malignant thyroid nodules or assess the functional status of the
thyroidnodule (4–7). Inorder to decrease the risk of unnecessary
surgery, aswell as the ﬁnancial burden to the community, there is
a need for a new non-invasive pre-surgical diagnostic test (8).
Free diffusion is the process of random thermal motion of mol-
ecules, which is termed Brownian motion. The MR diffusion
technique involves the diffusion of water protons in the tissue
that derives from the diffusion of extracellular water protons,
transport of water protons through the cell membranes, and dif-
fusion of intracellular water protons. This motion is interrupted
byﬁbers, intracellular organelles, so any architectural changes in
the tissue will alter the diffusion coefﬁcient of the tissue. Thus,
signal intensity of diffusion-weighted MR images and ADCs
of the tissues vary according to the microstructure and physio-
logic state of the tissues (9).
The application of DWI in the head and neck region has
been limited because the images in this area are likely to have
motion related artifacts from respiratory and swallowing
movements, and susceptibility artifacts due to the anatomic
heterogeneity of the area and adjacent air and bone, however
the development of new applications allows the use of DWI
in the evaluation of head and neck tumors, salivary gland
tumors and cervical lymphadenopathy (9–12).
There are few literatures related to ADC values of thyroid
nodules (3,13,15). In some literatures (3,13,14) a lower ADCwas observed in malignant nodules than those of benign ones,
while in another literature (15) a higher ADC value was
observed in thyroid carcinoma than adenoma.
Magnetic resonance spectroscopy is the only non-invasive
technique that measures chemicals and metabolites in the
body. The metabolites are measured due to their slightly differ-
ent magnetic frequency or chemical shifts. Malignant cells pro-
duce a large number of 1H-NMR visible molecules, few of
which are observed in normal healthy tissues and this can be
used as a diagnostic modality for various cancers (16–19).
Proton magnetic resonance spectroscopy (1H-MRS) is
being used to evaluate cancers in many regions of the body,
but there are many technical difﬁculties in the neck region such
as shimming and subject motion for in vivo spectroscopy (8).
Few literature works about the role of magnetic resonance
spectroscopy in thyroid lesions were carried out. Most of the
studies done initially were ex vivo, where magnetic resonance
spectroscopy was performed on FNAC specimen or on surgi-
cal excisional biopsy. (20–22).
Limited in vivo studies have been carried out (8,23), one
study (8) was performed to assess the feasibility of performing
in vivo 1H-MRS of thyroid cancer and to document its spectral
proﬁle. It did not, however, set out to distinguish malignant
from benign tumors.
To the best of our knowledge no previous studies have eval-
uated the results of the combined technique of DWI and MR
spectroscopy regarding the differentiation of benign and
malignant thyroid nodules.
The goal of this study is to evaluate the role of the com-
bined technique of DWI and MR spectroscopy in differentiat-
ing benign from malignant thyroid nodules and its correlation
with histopathological results as the reference standard.2. Materials and methods
2.1. Patients
This prospective study comprised of 46 patients with thyroid
nodules based on clinical examination and ultrasonography
and will undergo surgery or FNAB. All patients underwent
MRI including DWI, and MR spectroscopy within 2–5 days
prior to the surgery or FNAB. Nine patients were excluded
from the study. Three patients had motion artifacts (one on
DWI and two on MRS) and four patients had poor image
quality on DWI and two patients were excluded because of
non diagnostic cytology ﬁndings on FNAB. So a total of 37
patients (28 female and nine males) were included in the study
with age range (23–69 years) and mean age of 42 years.
Table 1 Mean ADC in benign and malignant thyroid lesions.
Malignant (n= 19) Benign (n= 37) T-test p value
ADC (Mean ± SD)·103 mm2/s 0.89 ± 0.27 1.85 ± 0.24 13.3 <0.0001
Fig. 1 ROC curve of ADC values for the differentiation of
benign from malignant thyroid nodules. The area under the curve
is 0.98.
Role of diffusion-weighted imaging with ADC mapping and in vivo 1H-MR spectroscopy in thyroid nodules 185Institutional review board approval and informed consent was
taken for all patients.
2.2. MR imaging protocol
MR imaging was performed with use of a 1.5-T MR (Achieva,
PhilipsMedical Systems, Netherland B.V.) by using a neck circu-
lar polarization surface coil. Patientswerepositioned in the supine
position and were informed to avoid movement and swallowing
during the examination. Scout scans were taken in axial, coronal
and sagittal planes. After localizing the lesion several sequences
were taken including axial T1-weighted images [repetition time
(TR) ms/echo time (TE) ms: 500–600/8–9] and axial and coronal
T2-weighted fast spin echo images (TR/TE: 3000/100) with a sec-
tion thickness of 2–4 mm, an intersection gap of 1 mm, a ﬁeld of
view (FOV) of 220–250 mm and a ﬂip angle of 90.
Diffusion-weighted images were obtained in the axial plane
using single shot echo planar imaging (EPI) sequence. Imaging
parameters were TR/TE 2000–2600 ms/64–70 ms, 3–4 mm
slice thickness, 1 mm intersection gap, FOV 230–255 mm.
The images were acquired using b values (0 and 500 s/mm2)
with an average scan time of 34 s. Apparent diffusion coefﬁ-
cient (ADC) maps were automatically calculated by MRI ma-
chine software and included in the sequence.
Magnetic resonance spectroscopy was done for all patients.
After lesion localization the volume of interest was positioned
on the lesion in three planes (axial, sagittal and coronal planes)
and carefully adjusted on the lesion and excluding the normal
structures. Point resolved spectroscopic sequence (PRESS) –
single voxel technique was done with the following parameters;
repetition time (TR)/echo time (TE) 2000/136 ms, signal acqui-
sition 64, spectral width 1000 Hz, number of points 512 fol-
lowed by water suppression and data acquisition then the
data are processed automatically with an average scan time
of 4:52 min. Spectra are assessed for the presence of choline
(cho) peak at 3.22 ppm.
2.3. Image analysis and data interpretation
MR images were evaluated independently by the two radiolo-
gists sharing in the study. Conventional T1 and T2-weighted
images were assessed for evaluation of the lesion. The ADC
maps generated from DWI were used for the measurement
of ADC values. The region of interest (ROI) ranged from 20
to 60 mm2 depending on the lesion size and is placed on the
nodule at ADC map. ROIs were placed in the center of the le-
sion in cases of solid nodules and on the solid portion of the
lesion in cases of mixed solid-cystic thyroid nodules. The
ADC values are expressed in square millimeters per second.
MR spectra were assessed for the presence of choline peak.
2.4. Statistical analysis
The patients were divided into benign and malignant nodules
regarding the histopathological results. Statistical analysiswas done using SPSS version 10. The mean and standard devi-
ations for ADC were calculated for the benign and the malig-
nant nodules in all cases. T test was used to assess the
difference in mean ADC values between benign and malignant
cases.
We used the receiver operating characteristic (ROC) curve
to evaluate the diagnostic capability of the ADC value for
use in the differentiation between benign and malignant thy-
roid nodules, and then we used multiple thresholds of ADC
values in order to select the best one (cut of value) determined
by Kappa test for differentiating benign from malignant
nodules.
The sensitivity and the speciﬁcity of DWI, MR spectros-
copy and both techniques are calculated. The probability
(p-value) was considered signiﬁcant when (p< 0.05).
3. Results
Thirty-seven patients with 56 thyroid nodules are included in
the study. Twenty-three patients had solitary thyroid nodules,
12 patients each had two nodules and three patients each had
three thyroid nodules. The mean size of the nodules was
1.6 ± 0.8 cm with their sizes ranging from 0.7 to 3.4 cm. There
were 37 benign and 19 malignant nodules (10 papillary carci-
noma, seven follicular carcinoma and two lymphoma) accord-
ing to the histopathological results. The mean ADC of the
benign thyroid nodules was 1.85 ± 0.24 · 103 mm2/s (ranged
from 1.48 to 2.24 · 103 mm2/s) (Figs. 5–7) while the mean
ADC of the malignant thyroid nodules was 0.89 ±
0.27 · 103 mm2/s (ranged from 0.53 to 1.06 · 103 mm2/s)
(Figs. 3 and 4). There was a signiﬁcant difference in the ADC
186 M.A. El-Hariri et al.values of benign and malignant thyroid nodules (p value
<0.0001) (Table 1).
Receiver operating characteristic (ROC) curve was used to
evaluate the diagnostic capability of the ADC value in differ-Fig. 2 (a and b) Pie chart shows the correlation of MR
Fig. 3 Lymphoma: axial T2WI (a) shows a small well deﬁned hyperin
lesion is hyperintense and it is of low signal intensity at ADC map (c) w
choline peak.entiating benign from malignant thyroid nodules (Fig. 1).
The area under the curve (AUC) was 0.98% & 95% CI
(0.96–1.00). The ADC value of 1.5 · 103 mm2/s was used as
a cut-off value for the differentiation of benign from malignantspectroscopic ﬁndings with histopathological results.
tense nodule at the right thyroid lobe. At DWI b 500 s/mm2 (b) the
ith ADC value 0.78 · 103 mm2/s. MRS (d) shows the presence of
Fig. 4 Follicular carcinoma: axial T1 (a) and T2WI (b) show a well deﬁned right thyroid nodule displaying low signal intensity at T1,
slightly high signal intensity at T2WI with intralesional hemorrhagic contents displaying high signal intensity at T1 and T2WIs. The lesion
is hyperintense at DWI b 500 s/mm2 (c) and is of low signal intensity at ADC map (d) with the ADC value 0.82 · 103 mm2/s. MRS (e)
shows the presence of choline peak.
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test & p value were 94%, 95%, 94%, 95%, 0.84 and <0.0001,
respectively.
At MR spectroscopy, malignant thyroid nodules (Fig. 2)
showed signiﬁcant choline peak in 18 out of 19 cases whilebenign nodules showed choline peak in only 4 out of 37 cases
(Table 2).
The sensitivity, speciﬁcity, PPV &NPV of MRS in differen-
tiating benign and malignant thyroid nodules were 94.7%,
89.2%, 81.8%, 97.1% respectively withKappa test 0.8 and p va-
Fig. 5 Follicular adenoma: axial (a) and coronal (b) T2WI shows a well deﬁned hyperintense nodule at the right thyroid lobe. At DWI b
500 s/mm2 (c) the lesion shows no hyperintensity. The lesion is hyperintense at ADC map (d) with the ADC value 1.91 · 103 mm2/s.
MRS (e) shows no choline peak.
188 M.A. El-Hariri et al.lue <0.0001 (Table 3). The sensitivity, speciﬁcity, PPV &NPV
of both DWI andMRS in differentiating benign and malignant
thyroid nodules were 96%, 100%, 100%, 97% respectively
with Kappa test 0.96 and p value <0.0001 (Table 3).4. Discussion
Thyroid nodules are very common and sonographically can be
detected in up to 27% of general population (24). The majority
Fig. 6 Colloid adenoma: axial (a) and coronal (b) T2WIs show two well deﬁned hyperintense thyroid nodules, one is at the right and the
other is at the left thyroid lobe. At DWI b 0 s/mm2 (c) the lesions are hyperintense and are of low signal intensity at DWI b 500 s/mm2 (d).
Both lesions are of high signal intensity at ADC map (e) with ADC value is 2.08 · 103 mm2/s. MRS (f) of the right thyroid nodule shows
no choline peak.
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malignant ones in order to decrease the risk of unnecessary sur-
gery for the benign thyroid nodules, as well as the ﬁnancial bur-den. Scintigraphy and ﬁne-needle aspiration cytology (FNAC)
are the common methods to evaluate thyroidal nodules. The
main purpose of magnetic resonance imaging (MRI) is to eval-
Fig. 7 Colloid adenoma: T1 (a) and T2WI (b) show a well deﬁned nodule at the right thyroid lobe and isthmus displaying low signal
intensity at T1 and intermediate signal intensity at T2WI with small intralesional cystic areas displaying high signal intensity at T2WI. The
lesion is hypointense at DWI (c) and hyperintense at ADC map (d) with the ADC value 1.3 · 103 mm2/s. MRS (e) shows small non-
signiﬁcant choline peak.
190 M.A. El-Hariri et al.uate deep disease and metastatic spread. New radiological
imaging techniques might be promising for the differential
diagnosis of thyroid nodules. Diffusion-weighted imaging(DWI) is one of the functional MRI modalities, which allows
quantitative measurement of the motion of water molecules in
lesions (3). Any change in the tissue structure will affect the intra
Table 2 MRS in benign and malignant thyroid lesions.
Choline peak Malignant (n= 19) Benign (n= 37) Total
Present 18 4 22
Absent 1 33 34
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coefﬁcient and the signal intensity of diffusion-weighted imag-
ing (25,9,26).
In this study the mean ADC (b value 0 and 500 s/mm2) of
the benign thyroid nodules was 1.85 ± 0.24 · 103 mm2/s
while the mean ADC of the malignant thyroid nodules was
0.89 ± 0.27 · 103 mm2/s. The ADC values of malignant thy-
roid nodules were signiﬁcantly lower than the ADC values of
benign thyroid nodules (p value <0.0001).
In agreement with this study, Razek et al. (13) reported that
there was a signiﬁcant difference in ADC values of benign and
malignant thyroid nodules. All benign nodules had higher mean
ADC values (1.8 ± 0.27 · 103 mm2/s) compared with the
malignant ones (0.73 ± 0.19 · 103 mm2/s) with p= 0.0001.
Erdem et al. (3) found that the mean ADC values of thyroid
nodules were 2745.3 ± 601.1 · 106 mm2/s in the benign group
and 695.2 ± 312.5 · 106 mm2/s in the malignant group with
signiﬁcant differences between benign and malignant nodules
(p= 0.0001). Bozgeyik et al. (14) used multiple b values to dif-
ferentiate benign from malignant thyroid nodules and reported
that the ADC value of benign nodules for b values 100, 200, and
300 s/mm2 ranged from 1.37 to 4.10 · 103, 0.70 to 3.17 · 103,
and 0.34 to 2.16 · 103 mm2/s, respectively. ADC values were
lower in malignant nodules than in the benign group. ADC val-
ues of malignant nodules for b values 100, 200, and 300 s/mm2
ranged from 0.38 to 2.05 · 103, 0.14 to 1.29 · 103, and 0.11 to
0.62 · 103 mm2/s, respectively.
The explanation for the low ADC values in cancer group is
the increase of cellularity in cancer, restriction of both the
intercellular distance, and the diffusion of water from extracel-
lular into the intracellular space, also the cellular barriers in a
tissue characterized by signiﬁcantly high cellular density with a
high nucleus/cytoplasm ratio may have a limiting effect on
water molecule diffusion (27–29).
On the other hand Schueller-Weidekamm et al. (30), using b
value 800 in their study on cold thyroid nodules found lowADC
values for adenomas (1.93 · 103 mm2/s) and high ADC values
in thyroiditis and thyroid carcinomas (P2.73 · 103 mm2/s).
Their explanation was that thyroid carcinoma cannot be com-
pared with other malignancies in the body as the cellular com-
ponents depend on the macrofollicular production of
thyreoglobulin, which results in an unrestricted diffusion capac-
ity. In addition, the presence of microcalciﬁcations inﬂuences
the DWI and signal intensities.
In the present study the ROC curve analysis showed that the
area under the curve (AUC) was 0.98% & 95% CI (0.96–1.00)
in differentiating benign from malignant nodules. When ADCTable 3 The sensitivity, speciﬁcity, PPV, NPV, Kappa test and p v
Sensitivity (%) Speciﬁcity (%) PPV
DWI 94 95 94
MRS 94.7 89.2 81.8
DWI & MRS 96 100 100value of 1.5 · 103 mm2/s was used as a cut-off value for the dif-
ferentiation of benign from malignant thyroid nodules the sen-
sitivity, speciﬁcity, PPV, NPV, Kappa test & p value were 94%,
95%, 94%, 95%, 0.84 and <0.0001, respectively. Razek et al.
(13) reported an ADC value of 0.98 · 103 mm2/s as an indica-
tor of malignancy, with a sensitivity of 97.5%, a speciﬁcity of
91.7%, and an accuracy of 98.9%. Bozgeyik et al. (14) found
that area under the curve (AUC) and cut-off values differentiat-
ing benign from malignant for b values 100, 200, and 300 were
0.997 and 1.45 · 103 mm2/s, 1.00 and 0.65 · 103 mm2/s, and
0.884 and 0.36 · 103 mm2/s, respectively.
Due to the variation in the cut-off values for predicting thy-
roid carcinoma in different studies the exact threshold value
for predicting malignancy in thyroid nodules should be deter-
mined for each MR imaging unit because there are some
variations in MR imaging systems, pulse sequences, and coils
(15).
Malignant cells produce a large number of 1H-NMR visible
molecules, few of which are observable in normal healthy tis-
sues. This idea is used as a diagnostic modality for various can-
cers (17,18). The choline peak at 3.22 ppm is predominantly
due to glycerophosphocholine and glycerophosphoethanol-
amine that form phospholipids of the cell membranes. The
choline content rises in malignancy because of rapid multipli-
cation and proliferation of cells. Height of choline peak de-
pends on the amount and nature of tissue under voxel (16).
In vivo 1H-MRS has the advantage that it allows pre-oper-
ative evaluation, samples a greater volume of tissue, and the
spectra are not inﬂuenced by the potential effects of oxygen
disruption once the tissue is removed. There are technical dif-
ﬁculties when performing spectroscopy of the thyroid. These
problems include movement of the tumor as a result of swal-
lowing and breathing, shimming difﬁculties arising from large
magnetic susceptibility differences between neck tissues and air
in the trachea, and contamination of the spectra by adjacent
fat. In addition, at present, spectroscopy can only be per-
formed on relatively large tumors, as a result many of the more
common types of thyroid cancer are too small for evaluation;
however, it is possible to perform in vivo 1H-MRS on tumors
greater than 1 cm3 (8).
In this study malignant thyroid nodules showed signiﬁcant
choline peak in 18 out of 19 cases however benign nodules
showed choline peak in only 4 out of 37 cases. Choline peak
observed in benign cases can be explained by rapid turnover
of cells in a hyperplastic nodule (23). The sensitivity, speciﬁc-
ity, PPV & NPV of MRS in differentiating benign and malig-
nant thyroid nodules were 94.7%, 89.2%, 81.8%, 97.1%,
respectively (Kappa test 0.8 and p value <0.0001). Gupta et
al. (23) had eight malignant cases and 18 benign cases. All
eight malignant cases showed prominent choline peak, and
mall choline peak was also observed in two benign cases; With
MRS sensitivity 100%, and speciﬁcity 88.88%. King et al. (8)
on their study on eight malignant thyroid carcinomas found
seven cases (87%) had choline peak.alue for DWI and MRS.
(%) NPV (%) Kappa test (%) p value (%)
95 0.84 <0.0001
97.1 0.80 <0.0001
97 0.96 <0.0001
192 M.A. El-Hariri et al.To our knowledge no previous studies were performed to
evaluate the role of combined DWI and MRS in thyroid
nodules with histopathological examination as a reference
standard; Our results showed that the sensitivity, speciﬁcity,
PPV & NPV of DWI and MRS together in differentiating be-
nign from malignant thyroid nodules were 96%, 100%, 100%,
97%, respectively (Kappa test 0.96 and p value <0.0001)
which is higher than DWI or MRS.
In conclusion, DWI and MRS are promising, feasible, and
non-invasive techniques that do not require the administration
of contrast media; and the combination of DWI with calcu-
lated ADC values and metabolite spectrum acquired by
MRS is a promising approach that adds more information
to MRI in differentiating benign from malignant thyroid nod-
ules. Our preliminary results showed that both DWI and MRS
should be considered an additional and complementary tool to
conventional MRI for differentiating benign from malignant
thyroid nodules. However, further studies including a larger
number of patients are required, to conﬁrm our results.
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